Manager × security

Richmond Brothers, Inc. HRTX holdings history

Who else holds this security? →

HERON THERAPEUTICS INC · CUSIP 427746102 · CIK 1540462

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Richmond Brothers, Inc. reported 1.79M HRTX (shares), valued at $764.96K, or 0.40% of its reported non-derivative portfolio. Filed 2026-08-11.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
0.40%
Shares
1.79M
1,792,319
Reported value
$764.96K
USD

Shares increased 24.75%; reported value decreased 33.45%, and weight changed -0.37 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20260.40%1,792,319SEC filing ↗Filed Aug 11, 2026Combination report
Q1 20260.77%1,436,705SEC filing ↗Filed May 11, 2026Combination report
Q4 20250.47%572,118SEC filing ↗Filed Feb 12, 2026Combination report
Q3 20250.46%572,118SEC filing ↗Filed Nov 10, 2025Combination report
Q2 20250.75%554,469SEC filing ↗Filed Aug 8, 2025Combination report
Q1 20250.76%544,901SEC filing ↗Filed May 2, 2025Combination report
Q4 20240.63%642,339SEC filing ↗Filed Feb 11, 2025Combination report
Q3 20240.63%510,782SEC filing ↗Filed Nov 12, 2024Combination report
Q2 20242.47%356,558SEC filing ↗Filed Aug 12, 2024
Q1 20241.52%296,706SEC filing ↗Filed May 9, 2024
Q4 20230.88%296,706SEC filing ↗Filed Feb 8, 2024
Q3 20230.20%103,009SEC filing ↗Filed Nov 3, 2023

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20230.20%103,009$106.10KThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Nov 3, 2023
Q4 20230.88%296,706$504.40KShares increased 188.04%; reported value increased 375.40%, and weight changed +0.68 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 8, 2024
Q1 20241.52%296,706$821.88KShares unchanged; reported value increased 62.94%, and weight changed +0.64 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 9, 2024
Q2 20242.47%356,558$1.25MShares increased 20.17%; reported value increased 51.84%, and weight changed +0.95 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 12, 2024
Q3 20240.63%510,782$1.02MShares increased 43.25%; reported value decreased 18.55%, and weight changed -1.84 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 12, 2024
Q4 20240.63%642,339$982.78KShares increased 25.76%; reported value decreased 3.31%, and weight changed +0.00 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 11, 2025
Q1 20250.76%544,901$1.20MShares decreased 15.17%; reported value increased 21.98%, and weight changed +0.13 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 2, 2025
Q2 20250.75%554,469$1.15MShares increased 1.76%; reported value decreased 4.26%, and weight changed -0.01 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 8, 2025
Q3 20250.46%572,118$720.87KShares increased 3.18%; reported value decreased 37.19%, and weight changed -0.29 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 10, 2025
Q4 20250.47%572,118$743.75KShares unchanged; reported value increased 3.17%, and weight changed +0.01 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 12, 2026
Q1 20260.77%1,436,705$1.15MShares increased 151.12%; reported value increased 54.55%, and weight changed +0.30 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 11, 2026
Q2 20260.40%1,792,319$764.96KShares increased 24.75%; reported value decreased 33.45%, and weight changed -0.37 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 11, 2026
Richmond Brothers, Inc. · HERON THERAPEUTICS INC

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1540462","quarter":"2026Q2","cusip":"427746102"}

get_institutional_manager_history
{"cik":"1540462","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.